NASDAQ:APYX - Apyx Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $12.25
  • Forecasted Upside: 231.08 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$3.70
▲ +0.26 (7.56%)

This chart shows the closing price for APYX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Apyx Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APYX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APYX

Analyst Price Target is $12.25
▲ +231.08% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Apyx Medical in the last 3 months. The average price target is $12.25, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 231.08% upside from the last price of $3.70.

This chart shows the closing price for APYX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Apyx Medical. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/24/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/25/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/20/2022Lake Street CapitalInitiated CoverageBuy$12.00Medium
5/12/2022Piper SandlerLower Price Target$12.00 ➝ $6.00High
3/22/2022Colliers SecuritiesReiterated RatingBuyLow
3/17/2022Piper SandlerLower Price Target$20.00 ➝ $12.00Medium
11/12/2021JMP SecuritiesReiterated RatingBuy$17.00High
11/11/2021Piper SandlerBoost Price TargetOverweight$14.00 ➝ $20.00High
8/13/2021JMP SecuritiesBoost Price TargetMarket Outperform$12.00 ➝ $14.00Medium
6/28/2021Colliers SecuritiesReiterated RatingBuy$14.00Medium
3/30/2021Colliers SecuritiesReiterated RatingBuyLow
1/29/2021Piper SandlerBoost Price TargetOverweight$8.00 ➝ $12.00Low
5/12/2020JMP SecuritiesLower Price TargetMarket Outperform$7.00 ➝ $5.00High
3/17/2020Piper SandlerLower Price Target$10.00 ➝ $7.00High
11/11/2019Piper Jaffray CompaniesBoost Price TargetOverweight$10.00High
5/8/2019Piper Jaffray CompaniesLower Price TargetOverweight$7.00High
4/2/2019Dougherty & CoLower Price TargetBuy ➝ Buy$12.00 ➝ $9.00High
4/2/2019JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$12.00 ➝ $8.00High
2/11/2019Piper Jaffray CompaniesBoost Price TargetOverweight$10.00Medium
9/14/2018Dougherty & CoReiterated RatingBuy$11.00Medium
(Data available from 5/26/2017 forward)

News Sentiment Rating

0.04 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2021
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/26/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2022
  • 2 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
5/26/2022

Current Sentiment

  • 2 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Apyx Medical logo
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More

Today's Range

Now: $3.70
Low: $3.37
High: $3.73

50 Day Range

MA: $4.98
Low: $3.11
High: $7.41

52 Week Range

Now: $3.70
Low: $3.01
High: $17.50

Volume

127,816 shs

Average Volume

120,806 shs

Market Capitalization

$127.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

Frequently Asked Questions

What sell-side analysts currently cover shares of Apyx Medical?

The following Wall Street sell-side analysts have issued stock ratings on Apyx Medical in the last year: Colliers Securities, JMP Securities, Lake Street Capital, Piper Sandler, and Zacks Investment Research.
View the latest analyst ratings for APYX.

What is the current price target for Apyx Medical?

0 Wall Street analysts have set twelve-month price targets for Apyx Medical in the last year. Their average twelve-month price target is $12.25, suggesting a possible upside of 231.1%.
View the latest price targets for APYX.

What is the current consensus analyst rating for Apyx Medical?

Apyx Medical currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe APYX will outperform the market and that investors should add to their positions of Apyx Medical.
View the latest ratings for APYX.

How do I contact Apyx Medical's investor relations team?

Apyx Medical's physical mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company's listed phone number is (727) 384-2323 and its investor relations email address is [email protected] The official website for Apyx Medical is www.apyxmedical.com. Learn More about contacing Apyx Medical investor relations.